Stryker declined comment on the current matter. This was an obvious response mandated by the Kalamazoo Mothership. In 2001 the FDA approved use of BMP-7 better known as OP-1 (Osteogenic Protein -1) for Non-Unions of the Tibia and in 2004 it was approved for Non-Unions of Spinal Fusions.
Spineblogger wants your voices to be heard! Did Stryker encourage off-label use? And, Did Stryker motivate its sales force with bonuses (anyone need a Z-3 and Rolex) for obtaining a certain number of approvals from facilities to run clinical trials. I know what I know! Spineblogger needs to know what you know. Why are Sales Reps going to jail, when some other folks in upper management need to be held accountable.
For a company that once practice revenue recognition anything is possible.